News NMD Pharma’s NMD670 Secures the US FDA’s Orphan Drug Designation to Treat Charcot-Marie-Tooth DiseaseBySenior EditorJanuary 6, 20250Comments
News JCR Pharmaceuticals and Modalis Progress into the Next Phase of Joint Research Agreement to Develop Gene TherapyBySenior EditorJanuary 6, 20250Comments
News Astellas’ Vyloy (Zolbetuximab) Secures the NMPA’s Approval as a 1L Treatment of Advanced G/GEJ AdenocarcinomaByRidhi RastogiJanuary 6, 20250Comments
VIEWPOINTS Biocon Biologics at EADV Congress 2024: Uwe Gudat in a Stimulating Dialogue Exchange with PharmaShotsBySaurabh ChaubeyJanuary 6, 20250Comments
Weekly Snapshot PharmaShots Weekly Snapshots (December 30th, 2024 – January 03rd, 2025)BySenior EditorJanuary 3, 20250Comments
News Atavistik Bio Partners with Pfizer to Discover Novel Precision Allosteric TherapeuticsBySenior EditorJanuary 3, 20250Comments
News Pharmanovia Collaborates with Radius Health to Commercialize Abaloparatide for Osteoporosis TreatmentBySenior EditorJanuary 3, 20250Comments
News GSK’s Nucala (Mepolizumab) Secures the NMPA’s Approval for Treating Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)ByRidhi RastogiJanuary 3, 20250Comments
News The China’s NMPA Grants Approval to Genesis Medtech’s Articulation Powered Stapler, iReach Omnia, for Complex SurgeriesBySenior EditorJanuary 3, 20250Comments
